Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyHumansMaleProstatic NeoplasmsHydroxymethylglutaryl-CoA Reductase InhibitorsCase-Control Studies
Statin and Other Antilipemic Use and Prostate Cancer: Results from the EPICAP Study.
Emilie Cordina-Duverger, Pierre-Jean Lamy, Brigitte Trétarre, Florence Menegaux
Published: 202510.1158/1055-9965.EPI-25-0919
Abstract
BACKGROUND: Antilipemic drugs have been hypothesized to decrease the risk of several cancers; however, results are still conflicting for prostate cancer. METHODS: We used data from the EPICAP study, a French population-based case-control study includ…
Preview only. Read the full abstract at the source